2021
DOI: 10.1007/s10384-021-00821-z
|View full text |Cite
|
Sign up to set email alerts
|

Systematic review of clinical research on regenerative medicine for the cornea

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
6
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 10 publications
(9 citation statements)
references
References 63 publications
0
6
0
Order By: Relevance
“…LSCD is a severe condition causing cornea opacification, conjunctival pannus, and blindness that can be secondary to chemical or thermal injuries, autoimmune diseases such as the Stevens-Johnson syndrome, mucous membrane pemphigoid, and hereditary diseases such as aniridia [43]. Current treatments are challenging, especially in cases with structural damage of the limbal area, which is not a candidate to cell therapy.…”
Section: Discussionmentioning
confidence: 99%
“…LSCD is a severe condition causing cornea opacification, conjunctival pannus, and blindness that can be secondary to chemical or thermal injuries, autoimmune diseases such as the Stevens-Johnson syndrome, mucous membrane pemphigoid, and hereditary diseases such as aniridia [43]. Current treatments are challenging, especially in cases with structural damage of the limbal area, which is not a candidate to cell therapy.…”
Section: Discussionmentioning
confidence: 99%
“…We conducted the world's first prospective, multi-center, government-controlled pivotal clinical trial of cultivated limbal epithelial cell sheets transplanted to the eyes of patients with J o u r n a l P r e -p r o o f LSCD. Although similar clinical studies have been conducted, [10][11][12] no clinical trial has been performed that adhered to the GCP stipulations within a defined clinical protocol and the use of strict quality control for cell sheets fabricated in a GMP-grade facility. Our data, including the trial results reported here, were reviewed by the Ministry of Health, Labour and Welfare in Japan.…”
Section: Discussionmentioning
confidence: 99%
“…6,7 Conversely, cultivated limbal stem cells have been successfully used for ocular surface reconstruction in patients with unilateral LSCD, 8,9 and it is expected that this surgical approach will become more widely used as the cell sheets become more readily available. Other clinical studies have described the use of ex vivo expanded limbal epithelial cells to treat LSCD, [10][11][12] but all these studies had limitations in that they either had a retrospective single-center study design or heterogeneity among transplanted cells because of the lack of evaluation under defined shipment criteria. More importantly, no clinical trial has been performed that adhered to Good Clinical Practice (GCP) stipulations within a defined clinical protocol and the use of strict quality control for cell sheets fabricated in a Good Manufacturing Practice (GMP)-grade facility.…”
Section: Introductionmentioning
confidence: 99%
“…Tissue sections were evaluated using the histological grading score described by Mankin [ 35 ], which was modified as described previously [ 28 ]. The total score ranges from 0 to 14 and includes scores from four categories: cartilage structure, cellular abnormality, matrix staining, and tidemark integrity.…”
Section: Methodsmentioning
confidence: 99%
“…We believed that a feasible approach to overcome these setbacks is to use cell sheet technology. The use of cell sheets has been described in regenerative medicine applications, including the regeneration of myocardium [ 27 ], cornea [ 28 ], and renal tissues [ 29 ]. Recently, this technology has also been used to develop chondrocytes sheet for the repair of AC defects.…”
Section: Introductionmentioning
confidence: 99%